This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Drug patents are a form of intellectual property protection that grants pharmaceuticalcompanies exclusive rights to manufacture, sell, and profit from their innovations for a set period. This exclusivity is the lifeblood of the industry, allowing companies to recoup their substantial R&D investments and fund future discoveries.
This article aims to provide a comprehensive overview of the key aspects of the regulatory framework, highlighting the requirements and challenges faced by pharmaceuticalcompanies seeking to introduce generic drugs into the Japanese market. Pharmaceutical Regulations in Japan 2020. Regulatory System on Generic Drugs in Japan.
Pharmaceuticalcompanies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Having worked for CROs since graduating, Sophie joined Pfizer in 2011 and has had various roles within the UK and now global groups.
11 have recently conducted an analysis of international HTA submissions from 2011-2019 to determine the acceptability of single arm clinical studies and ECs as part of the drug reimbursement process. 2011 May; 46(3): 399–424. Patel et al. FDA presentation. Available at: [link]. Multivariate Behav Res. doi: 1080/00273171.2011.568786.
In the 2011 Census, 8% of the population in England listed a language other than English as their ‘first language’, and 1.3% The first step to successful healthcare communication is ensuring it is delivered in a language which is understood by the target group using words and terminology that resonate with them. That won’t always be English.
In 2011, Alfred was a fit and healthy 54-year-old providing security for music’s A-listers on global tours. He also sits on a patient consultation panel for pharmaceuticalcompany Parexel. I think pharmaceuticalcompanies are cottoning on to that now, but there’s still a lot of mistrust.
A study investigating the trend for existing pharmaceuticalcompanies to outsource to contracted development and manufacturing organisations (CDMOs), analysing the position of companies manufacturing monoclonal antibody drugs (mAbs). Yoshiura et al. Yoshiura et al.
Pharmaceuticalcompanies dealing with the US will be closely watching the debate surrounding a proposed revision by the Senate which could see the watering down of some requirements, and an increase in others, under its Physician Payments Sunshine Act (S.2029). Over the years, the company has had time to oversee these changes.
But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.
Although the sticker shock that was at first associated with Yervoy (ipilimumab) in 2011 – in the early days of immuno-oncology monoclonal antibodies – has fallen by the wayside, especially in light of CAR-Ts and other “one and done” cell and gene therapies, the field of non-orphan oncology remains a target for cost savings by payers.
Alongside its support for research carried out by patients, advocacy groups, pharmaceuticalcompanies, and academic medical centers, Rare Central also enables scientists and researchers to study deidentified data across a family of diseases with the appropriate governance structure and data sharing in place.
If pharmaceuticalcompanies do not use this data, someone else will. In 2017, Garabedian joined Perceptive Advisors to develop their Venture Fund strategy, which invests in early-stage companies across biotech, medtech and healthtech. This data will exist whether you collect it as part of a clinical trial or not.
Lastly, there is growing prominence and interest in radioligand therapeutics within major pharmaceuticalcompanies, who are increasingly investing in this field, evident through recent acquisitions of Point Biopharma and RayzeBio. What makes targeted alpha therapies a promising new approach against cancer?
Herbal medicines placed on the market since April 2011 must have either a traditional herbal registration (THR) or a Marketing Authorisation (MA). Prior to joining Fieldfisher, Taly spent four years working as in-house counsel for a leading tech company helping launch products across multiple EU markets. 2012/1916).
Beyond clinical trials, what other challenges are impacting pharmaceuticalcompanies today? You see very few cardiovascular companies as a startup biotech, and there are reasons for that. Michael served as President of the National Lipid Association from 2010 to 2011.
The next step is having a pharmaceuticalcompany manufacture a product that can be FDA-approved for OTC use. HRA Pharma , a French pharmaceuticalcompany acquired by Perrigo, is working with Ibis Reproductive Health to bring the product Opill to the US market. Oral contraception checks all of these boxes. What is Opill?
As technology has evolved, biotech and pharmaceuticalcompanies have increasingly leaned on AI to support drug development – including to make sense of the vast amounts of healthcare data available to them. Forging an AI-enabled path toward precision medicine. By 2025, pharma’s investment in AI is expected to reach $3 billion.
In 2011, following referral from another company, IMPACT (now part of Syner-G BioPharma Group) was contacted by a small development stage pharmaceuticalcompany located in the United Kingdom to assist them with pre-IND activities for a new chemical entity for the treatment of asthma.
Syngene’s collaboration with Zoetis started in 2011. Initially centered on Librela®, this agreement paves the way for developing and manufacturing other molecules in the coming years.
Pharmaceuticalcompanies, regulatory agencies and governments are becoming increasingly concerned about fraud and counterfeiting throughout the pharmaceutical supply chain, especially with the cost of drugs going up. Europe is favouring 2D data matrix codes to encode information while the US is tending more towards RFID. .
FDA – Process Validation Guidelines (published in January 2011) are crucial for maintaining the quality management system. Prev PREVIOUS POST Author: Kazi Hasan Kazi is a seasoned pharmaceutical industry professional with over 20 years of experience specializing in production operations, quality management, and process validation.
I really wish that this supplement would come back, and it’s one of the drug entities I would like to create if I ever win the lottery and start my own pharmaceuticalcompany. 2011-0228 [2] Müssig K, Künle A, Säuberlich AL, et al. 2011-3350 [19] Eschler DC, Hasham A, Tomer Y. Published 2011 Jan 13. doi:10.1210/jc.2011-0228
Between 2011 and 2020, 10 of the world’s largest pharmaceuticalcompanies paid a combined $1.34 billion in fines to the U.S. government for bribing foreign officials in order to boost purchases of their medicines.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content